Parexel sets up proof-of-concept unit
Parexel International has expanded its early phase drug development capabilities with a unit focused specifically on proof of concept studies.
Archives for October 1, 2008
Pfizer narrows research focus again
Pfizer is shifting its research focus to those diseases where its sees the potential for the biggest treatment improvements and profits, while dropping eight disease areas including cholesterol.
Novozymes' HyaCare Takes Top Innovation Award
Novozymes Biopolymer’s novel hyaluronic acid (HA) HyaCare has been named winner of this year’s gold innovation award at the CPhI worldwide conference in Frankfurt, Germany.
Drugmakers vow to disclose physician payments
US drug majors Eli Lilly and Merck & Co have said they will disclose payments made to physicians in a move towards greater transparency.
Pharma manufacturing: People on the move
in-PharmaTechnologist.com presents its latest round-up of personnel changes in the pharmaceutical manufacturing sector.